Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.

Swarts DRA, Voorham QJM, van Splunter AP, Wilting SM, Sie D, Pronk D, van Beurden M, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM, Bleeker MCG.

Cancer Med. 2018 Jul 20. doi: 10.1002/cam4.1633. [Epub ahead of print]

2.

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Babion I, Snoek BC, Novianti PW, Jaspers A, van Trommel N, Heideman DAM, Meijer CJLM, Snijders PJF, Steenbergen RDM, Wilting SM.

Clin Epigenetics. 2018 Jun 7;10:76. doi: 10.1186/s13148-018-0509-9. eCollection 2018.

3.

Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons.

Smid M, Coebergh van den Braak RRJ, van de Werken HJG, van Riet J, van Galen A, de Weerd V, van der Vlugt-Daane M, Bril SI, Lalmahomed ZS, Kloosterman WP, Wilting SM, Foekens JA, IJzermans JNM; MATCH study group, Martens JWM, Sieuwerts AM.

BMC Bioinformatics. 2018 Jun 22;19(1):236. doi: 10.1186/s12859-018-2246-7.

4.

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJG, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM.

Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.

PMID:
29632006
5.

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Coebergh van den Braak RRJ, Sieuwerts AM, Lalmahomed ZS, Smid M, Wilting SM, Bril SI, Xiang S, van der Vlugt-Daane M, de Weerd V, van Galen A, Biermann K, van Krieken JHJM, Kloosterman WP, Foekens JA; MATCH study group*, Martens JWM, IJzermans JNM.

Sci Rep. 2018 Mar 27;8(1):5242. doi: 10.1038/s41598-018-22532-1.

6.

Improved high-dimensional prediction with Random Forests by the use of co-data.

Te Beest DE, Mes SW, Wilting SM, Brakenhoff RH, van de Wiel MA.

BMC Bioinformatics. 2017 Dec 28;18(1):584. doi: 10.1186/s12859-017-1993-1.

7.

Molecular events leading to HPV-induced high grade neoplasia.

Wilting SM, Steenbergen RDM.

Papillomavirus Res. 2016 Dec;2:85-88. doi: 10.1016/j.pvr.2016.04.003. Epub 2016 Apr 12. Review.

8.

A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens.

Babion I, Snoek BC, van de Wiel MA, Wilting SM, Steenbergen RDM.

J Mol Diagn. 2017 Sep;19(5):625-637. doi: 10.1016/j.jmoldx.2017.04.010.

PMID:
28826607
9.

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.

Verlaat W, Snijders PJF, Novianti PW, Wilting SM, De Strooper LMA, Trooskens G, Vandersmissen J, Van Criekinge W, Wisman GBA, Meijer CJLM, Heideman DAM, Steenbergen RDM.

Clin Cancer Res. 2017 Jul 15;23(14):3813-3822. doi: 10.1158/1078-0432.CCR-16-2641. Epub 2017 Jan 24.

10.

Better diagnostic signatures from RNAseq data through use of auxiliary co-data.

Novianti PW, Snoek BC, Wilting SM, van de Wiel MA.

Bioinformatics. 2017 May 15;33(10):1572-1574. doi: 10.1093/bioinformatics/btw837.

PMID:
28073760
11.

Ridge estimation of the VAR(1) model and its time series chain graph from multivariate time-course omics data.

Miok V, Wilting SM, van Wieringen WN.

Biom J. 2017 Jan;59(1):172-191. doi: 10.1002/bimj.201500269. Epub 2016 Nov 7.

PMID:
27902843
12.

Immortalization capacity of HPV types is inversely related to chromosomal instability.

Schütze DM, Krijgsman O, Snijders PJ, Ylstra B, Weischenfeldt J, Mardin BR, Stütz AM, Korbel JO, de Winter JP, Meijer CJ, Quint WG, Bosch L, Wilting SM, Steenbergen RD.

Oncotarget. 2016 Jun 21;7(25):37608-37621. doi: 10.18632/oncotarget.8058.

13.

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.

Wilting SM, Miok V, Jaspers A, Boon D, Sørgård H, Lando M, Snoek BC, van Wieringen WN, Meijer CJ, Lyng H, Snijders PJ, Steenbergen RD.

Oncotarget. 2016 Jul 12;7(28):43805-43819. doi: 10.18632/oncotarget.9698.

14.

Better prediction by use of co-data: adaptive group-regularized ridge regression.

van de Wiel MA, Lien TG, Verlaat W, van Wieringen WN, Wilting SM.

Stat Med. 2016 Feb 10;35(3):368-81. doi: 10.1002/sim.6732. Epub 2015 Sep 13.

PMID:
26365903
15.

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H.

Epigenetics. 2015;10(10):970-80. doi: 10.1080/15592294.2015.1085140.

16.

Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.

Schütze DM, Kooter JM, Wilting SM, Meijer CJ, Quint W, Snijders PJ, Steenbergen RD.

Epigenetics. 2015;10(1):73-81. doi: 10.4161/15592294.2014.990787. Epub 2015 Jan 23.

17.

tigaR: integrative significance analysis of temporal differential gene expression induced by genomic abnormalities.

Miok V, Wilting SM, van de Wiel MA, Jaspers A, van Noort PI, Brakenhoff RH, Snijders PJ, Steenbergen RD, van Wieringen WN.

BMC Bioinformatics. 2014 Oct 2;15:327. doi: 10.1186/1471-2105-15-327.

18.

Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.

Hesselink AT, Heideman DA, Steenbergen RD, Gök M, van Kemenade FJ, Wilting SM, Berkhof J, Meijer CJ, Snijders PJ.

Int J Cancer. 2014 Aug 15;135(4):880-6. doi: 10.1002/ijc.28723. Epub 2014 Jan 28.

19.

Modeling the DNA copy number aberration patterns in observational high-throughput cancer data.

van Wieringen WN, Roś BP, Wilting SM.

Stat Appl Genet Mol Biol. 2013 Apr 19;12(2):143-74. doi: 10.1515/sagmb-2012-0020.

PMID:
23735435
20.

Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.

Lando M, Wilting SM, Snipstad K, Clancy T, Bierkens M, Aarnes EK, Holden M, Stokke T, Sundfør K, Holm R, Kristensen GB, Steenbergen RD, Lyng H.

J Pathol. 2013 May;230(1):59-69. doi: 10.1002/path.4168. Epub 2013 Mar 14.

PMID:
23335387
21.

Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.

Wilting SM, Verlaat W, Jaspers A, Makazaji NA, Agami R, Meijer CJ, Snijders PJ, Steenbergen RD.

Epigenetics. 2013 Feb;8(2):220-8. doi: 10.4161/epi.23605. Epub 2013 Jan 16.

22.

Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.

Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B, Steenbergen RD.

Genes Chromosomes Cancer. 2013 Jan;52(1):56-68. doi: 10.1002/gcc.22006. Epub 2012 Sep 14.

PMID:
22987659
23.

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.

Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, van Wieringen WN, Meijer GA, Kenter GG, Yi Y, le Sage C, Agami R, Meijer CJ, Steenbergen RD.

Oncogene. 2013 Jan 3;32(1):106-16. doi: 10.1038/onc.2012.20. Epub 2012 Feb 13.

PMID:
22330141
24.

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.

Bierkens M, Wilting SM, van Wieringen WN, van de Wiel MA, Ylstra B, Meijer CJ, Snijders PJ, Steenbergen RD.

BMC Cancer. 2012 Jan 24;12:36. doi: 10.1186/1471-2407-12-36.

25.

Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection.

Bierkens M, Wilting SM, van Wieringen WN, van Kemenade FJ, Bleeker MC, Jordanova ES, Bekker-Lettink M, van de Wiel MA, Ylstra B, Meijer CJ, Snijders PJ, Steenbergen RD.

Int J Cancer. 2012 Aug 15;131(4):E579-85. doi: 10.1002/ijc.26496. Epub 2011 Nov 17.

26.

DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.

van Boerdonk RA, Sutedja TG, Snijders PJ, Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus PE, Smit EF, Heideman DA.

Am J Respir Crit Care Med. 2011 Oct 15;184(8):948-56. doi: 10.1164/rccm.201102-0218OC. Epub 2011 Jul 28.

PMID:
21799074
27.

Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.

Overmeer RM, Louwers JA, Meijer CJ, van Kemenade FJ, Hesselink AT, Daalmeijer NF, Wilting SM, Heideman DA, Verheijen RH, Zaal A, van Baal WM, Berkhof J, Snijders PJ, Steenbergen RD.

Int J Cancer. 2011 Nov 1;129(9):2218-25. doi: 10.1002/ijc.25890. Epub 2011 Mar 11.

28.

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, le Sage C, Agami R, Snijders PJ, Steenbergen RD.

Mol Cancer. 2010 Jun 26;9:167. doi: 10.1186/1476-4598-9-167.

29.

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.

Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD.

J Pathol. 2009 Nov;219(3):327-36. doi: 10.1002/path.2598.

PMID:
19662663
30.

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.

Wilting SM, Smeets SJ, Snijders PJ, van Wieringen WN, van de Wiel MA, Meijer GA, Ylstra B, Leemans CR, Meijer CJ, Brakenhoff RH, Braakhuis BJ, Steenbergen RD.

BMC Med Genomics. 2009 Jun 1;2:32. doi: 10.1186/1755-8794-2-32.

31.

Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.

Wilting SM, Steenbergen RD, Tijssen M, van Wieringen WN, Helmerhorst TJ, van Kemenade FJ, Bleeker MC, van de Wiel MA, Carvalho B, Meijer GA, Ylstra B, Meijer CJ, Snijders PJ.

Cancer Res. 2009 Jan 15;69(2):647-55. doi: 10.1158/0008-5472.CAN-08-2478.

32.

Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.

Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, van Wieringen WN, Braakhuis BJ, Meijer GA, Ylstra B, Snijders PJ, Steenbergen RD.

Genes Chromosomes Cancer. 2008 Oct;47(10):890-905. doi: 10.1002/gcc.20590.

33.

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.

Overmeer RM, Henken FE, Snijders PJ, Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting SM, Murakami Y, Ito A, Meijer CJ, Steenbergen RD.

J Pathol. 2008 Aug;215(4):388-97. doi: 10.1002/path.2367.

PMID:
18498117
34.

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.

Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD.

Br J Cancer. 2007 Nov 19;97(10):1457-64. Epub 2007 Oct 30.

35.

Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.

de Wilde J, Wilting SM, Meijer CJ, van de Wiel MA, Ylstra B, Snijders PJ, Steenbergen RD.

Int J Cancer. 2008 Feb 15;122(4):877-88.

36.

DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma.

Vékony H, Ylstra B, Wilting SM, Meijer GA, van de Wiel MA, Leemans CR, van der Waal I, Bloemena E.

Clin Cancer Res. 2007 Jun 1;13(11):3133-9.

37.

CGHcall: calling aberrations for array CGH tumor profiles.

van de Wiel MA, Kim KI, Vosse SJ, van Wieringen WN, Wilting SM, Ylstra B.

Bioinformatics. 2007 Apr 1;23(7):892-4. Epub 2007 Jan 31.

PMID:
17267432
38.

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix.

Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM, Albertson DG, Coffa J, Schouten JP, van de Wiel MA, Meijer CJ, Steenbergen RD.

J Pathol. 2006 Jun;209(2):220-30.

PMID:
16538612
39.

HPV-mediated transformation of the anogenital tract.

Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ.

J Clin Virol. 2005 Mar;32 Suppl 1:S25-33. Review.

PMID:
15753009
40.

c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers.

Peltenburg LT, de Bruin EC, Meersma D, Wilting S, Jürgensmeier JM, Schrier PI.

Melanoma Res. 2004 Feb;14(1):3-12.

PMID:
15091188

Supplemental Content

Loading ...
Support Center